Skip to main content
Top
Published in: Clinical Rheumatology 3/2009

01-03-2009 | Case Report

Necrotising scleritis and connective tissue disease—three cases and a review

Authors: Sharmin Nizam, Annette Johnstone, Michael Green, Andrew Gough

Published in: Clinical Rheumatology | Issue 3/2009

Login to get access

Abstract

Necrotising scleritis is a severe form of anterior scleritis which is known to be associated with connective tissue disease but has not previously been reported in association with limited scleroderma. It is often a difficult condition to treat and without adequate early intervention leads to significant morbidity including visual loss. We report three cases of necrotising scleritis, two occurring in the context of previously unreported associations and a third case to compare presentation of the condition and highlight difficulties in management.
Literature
1.
go back to reference Nguyen QD, Foster CS (1999) Scleral patch graft in the management of necrotising scleritis. Int Ophthalmol Clin Winter 39(1):109–131CrossRef Nguyen QD, Foster CS (1999) Scleral patch graft in the management of necrotising scleritis. Int Ophthalmol Clin Winter 39(1):109–131CrossRef
2.
go back to reference McCluskey P, Wakefield D (1987) Current concepts in the management of scleritis. Arch Ophthalmol 16:169 McCluskey P, Wakefield D (1987) Current concepts in the management of scleritis. Arch Ophthalmol 16:169
3.
go back to reference McCluskey P, Wakefield D (1987) Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol 105:793–797PubMed McCluskey P, Wakefield D (1987) Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol 105:793–797PubMed
4.
go back to reference Foster CS, Forstot SL, Wilson LA (1984) Mortality rate in rheumatoid arthritis patients developing necrotising scleritis or peripheral ulcerative keratitis-effect of systemic immunosuppression. Ophthalmology 91:1253–1263PubMed Foster CS, Forstot SL, Wilson LA (1984) Mortality rate in rheumatoid arthritis patients developing necrotising scleritis or peripheral ulcerative keratitis-effect of systemic immunosuppression. Ophthalmology 91:1253–1263PubMed
5.
go back to reference Hakin KN, Ham J, Lightman SL (1991) Use of cyclosporin in the management of steroid dependent non-necrotising scleritis. Br J Ophthalmol 75(6):340–341PubMedCrossRef Hakin KN, Ham J, Lightman SL (1991) Use of cyclosporin in the management of steroid dependent non-necrotising scleritis. Br J Ophthalmol 75(6):340–341PubMedCrossRef
6.
go back to reference Wakefield D, McCluskey P (1989) Cyclosporin therapy for severe scleritis. Br J Ophthalmol 73:743–746PubMedCrossRef Wakefield D, McCluskey P (1989) Cyclosporin therapy for severe scleritis. Br J Ophthalmol 73:743–746PubMedCrossRef
7.
go back to reference McCluskey PJ, Wakefield D (1996) Scleritis and episcleritis. In: Pepose J, Holland GN, Wilhelmus KR (eds) Ocular infections and immunity. Mosby, St Louis, pp 642–662 McCluskey PJ, Wakefield D (1996) Scleritis and episcleritis. In: Pepose J, Holland GN, Wilhelmus KR (eds) Ocular infections and immunity. Mosby, St Louis, pp 642–662
8.
go back to reference Shah SS (1992) Low dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 99:1419PubMed Shah SS (1992) Low dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 99:1419PubMed
9.
go back to reference Zierhut M, Stubiger N, Siepmann K, Deuter CM (2005) MMF and eye disease. Lupus 14(Suppl 1):s50–54PubMedCrossRef Zierhut M, Stubiger N, Siepmann K, Deuter CM (2005) MMF and eye disease. Lupus 14(Suppl 1):s50–54PubMedCrossRef
10.
go back to reference Young AL, Wong SM, Leung ATS, Leung GYS, Chenge LL, Lam D (2005) Successful treatment of surgically induced necrotising scleritis with tacrolimus. Clin Experiment Ophthalmol 33:98–106PubMedCrossRef Young AL, Wong SM, Leung ATS, Leung GYS, Chenge LL, Lam D (2005) Successful treatment of surgically induced necrotising scleritis with tacrolimus. Clin Experiment Ophthalmol 33:98–106PubMedCrossRef
11.
go back to reference Atchia II, Kidd CE, Bell RW (2006) Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab. J Clin Rheumatol 12(6):291–293PubMedCrossRef Atchia II, Kidd CE, Bell RW (2006) Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab. J Clin Rheumatol 12(6):291–293PubMedCrossRef
12.
go back to reference Ashok D, Ayliffe WH, Kiely PDW (2005) Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy. Rheumatol 44:950–951CrossRef Ashok D, Ayliffe WH, Kiely PDW (2005) Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy. Rheumatol 44:950–951CrossRef
13.
go back to reference Lim L, Suhler EB, Smith JR (2006) Biologic therapies for inflammatory eye disease. Clin Exp Ophthalmol 34(4):365–374CrossRef Lim L, Suhler EB, Smith JR (2006) Biologic therapies for inflammatory eye disease. Clin Exp Ophthalmol 34(4):365–374CrossRef
14.
go back to reference Ahmadi-Simab K, Lamprecht P, Nolle B, Ai M, Gross WL (2005) Successful treatment of refractory anterior scleritis in primary Sjogren’s syndrome with rituximab. Ann Rheum Dis 64:1087–1088PubMedCrossRef Ahmadi-Simab K, Lamprecht P, Nolle B, Ai M, Gross WL (2005) Successful treatment of refractory anterior scleritis in primary Sjogren’s syndrome with rituximab. Ann Rheum Dis 64:1087–1088PubMedCrossRef
15.
go back to reference Cheung CM, Murray PI, Savage CO (2005) Successful treatment of Wegener’s granulamatosis associated scleritis with rituximab. Br J Ophthalmol 89:1542PubMedCrossRef Cheung CM, Murray PI, Savage CO (2005) Successful treatment of Wegener’s granulamatosis associated scleritis with rituximab. Br J Ophthalmol 89:1542PubMedCrossRef
Metadata
Title
Necrotising scleritis and connective tissue disease—three cases and a review
Authors
Sharmin Nizam
Annette Johnstone
Michael Green
Andrew Gough
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2009
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-1054-2

Other articles of this Issue 3/2009

Clinical Rheumatology 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.